<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
<head>

<title>MCSim Links</title>
<link rel="icon" href="mcsim.png" type="image/png">
</head>

<body>

<body style="color: rgb(0, 0, 128); background-color: rgb(255, 255, 255);"
      alink="#ff7f50" link="#802040" vlink="#000000">

<font color="#ff8800" size="+2">
<b>MCSim-related pages</b>
</font>

<dl>
  
  <dd><a href="http://en.wikipedia.org/wiki/MCSim">
  GNU MCSim page on Wikipedia</a></dd>

  <dd><a href="http://www.jstatsoft.org/index.php?vol=2">
  Journal of Statistical Software</a></dd>

  <dd><a href="http://lib.stat.cmu.edu/index.php">Data on Statlib for
  Gelman, Bois, Jiang, JASA, 1996 paper</a></dd>
 
  <dd><a href="http://sal.jyu.fi/">SAL-Numerical Analysis</a></dd>
 
  <dd><a href="http://www.stat.duke.edu/">Duke University:
  Institute of Statistics and Decision Sciences</a></dd>

  <dd><a href="http://www.fen.bris.ac.uk/engmaths/research/neural/software.html"
  >University of Bristol: Neural Network
  Information</a></dd>

  <dd><a href="http://bioweb.pasteur.fr/docs/gensoft-math.html">
  Pasteur Institute: Software</a></dd>
 
  <dd><a href="http://www.cooper.edu/engineering/chemechem/MMC/software.html"
  >Molecular Monte Carlo Software</a></dd>
 
  <dd><a href="http://www.delorie.com/gnu/docs/mcsim/">Delorie Free
  Software</a></dd>
 
  <dd><a href="http://makingsense.facilitatedsystems.com/2007/03/making-musical-sense-by-email-table-of.html">A
  real conversation supported by an MCSim simulation model</a></dd>

</dl>


<font color="#ff8800" size="+2">
<b>Scientific works acknowledging the use of MCSim</b>
</font>

<ol>

<li>Allen, B.C., Hack E.C., Clewell H.J., 2007,<br>
"Use of Markov chain Monte Carlo analysis with a physiologically-based
pharmacokinetic model of methylmercury to estimate exposures in
u.s. women of childbearing age".<br>
Risk Analysis, 27:947-959.</li><p>

<li>Banks H.T., Ma Y., Potter, L.K., 2005,<br>
"A Simulation-based comparison between parametric and nonparametric 
estimation methods in PBPK Models",<br>
Journal of Inverse and Ill-posed Problems, 13:1úÙÚÛ26.</li><p>

<li>Bernillon P., Bois F., 2000,<br>
"Statistical issues in toxicokinetic modeling: A Bayesian perspective",<br>
Environmental Health Perspectives, 108(suppl.5):883-893.</li><p>

<li>Bois F., 1999,<br>
"Analysis of PBPK models for risk characterization."<br>
Annals of the New York Academy of Sciences 895: 317-337.</li><p>

<li>Bois F., 2000,<br>
"Statistical analysis of Clewell et al. PBPK model of trichloroethylene 
kinetics."<br>
Environmental Health Perspectives 108 (suppl. 2): 307-316.</li><p>

<li>Bois F., 2000,<br>
"Statistical analysis of Fisher et al. PBPK model of trichloroethylene 
kinetics."<br>
Environmental Health Perspectives 108 (suppl. 2): 275-282.</li><p>

<li>Bois F., 2001,<br>
"Applications of population approaches in toxicology."<br>
Toxicology Letters 120:385-394.</li><p>

<li>Bois F., 2003,<br>
"Toxicokinetic modelling of 2,3,7,8-tetrachloro-p-dioxin blood 
concentration after ingestion by women."<br>
Environnement, Risque et Sante 2:45-53.</li><p>

<li>Bois F., Fahmy T., et al., 1997,<br>
"Dynamic modeling of bacteria in a pilot drinking water distribution 
system."<br>
Water Research 31:3146-3156.</li><p>

<li>Bois F., Gelman A., et al., 1996,<br>
"Population toxicokinetics of tetrachloroethylene."<br>
Archives of Toxicology 70: 347-355.</li><p>

<li>Bois F., Jackson E., et al., 1996,<br>
"Population toxicokinetics of benzene."<br>
Environmental Health Perspectives 104 (suppl. 6): 1405-1411.</li><p>

<li>Bois F., Krowech G., et al., 1995,<br>
"Human interindividual variability in metabolism: the example 
of 4-aminobiphenyl."<br>
Risk Analysis 15: 205-213.</li><p>

<li>Bois F., Maszle D., 1997,<br>
MCSim: A simulation program,<br>
Journal of Statistical Software, 
2(9):http://www.stat.ucla.edu/journals/jss/v02/i09.</li><p>

<li>Bois F., Paxman D., 1992,<br>
"An analysis of exposure rate effects for benzene using a physiologically 
based pharmacokinetic model."<br>
Regulatory Toxicology and Pharmacology 15: 122-136.</li><p>

<li>Bois F., Smith M., et al., 1991,<br>
"Mechanisms of benzene carcinogenesis: application of a physiological 
model of benzene pharmacokinetics and metabolism."<br>
Toxicology Letters 56: 283-298.</li><p>

<li>Bois F., Smith T., et al., 1999,<br>
"Optimal design for a study of butadiene toxicokinetics in humans."<br>
Toxicological Sciences 49: 213-224.</li><p>

<li>Bois F., Woodruff T.J., et al., 1991,<br>
"Comparison of three physiologically-based pharmacokinetic models of 
benzene disposition."<br>
Toxicology and Applied Pharmacology 110: 79-88.</li><p>

<li>Bois F., Zeise L., et al., 1990,<br>
"Precision and sensitivity analysis of pharmacokinetic models for cancer 
risk assessment: tetrachloroethylene in mice, rats and humans."<br>
Toxicology and Applied Pharmacology 102: 300-315.</li><p>

<li>Brochot C., Bessoud B., et al., 2006,<br>
"Evaluation of antiangiogenic treatment effects on tumors microcirculation 
by Bayesian physiological pharmacokinetic modeling and magnetic resonance 
imaging."<br>
Magnetic Resonance Imaging, 24:1059-1067.</li><p>

<li>Brochot C., Bois F., 2005,<br>
"Use of a chemical probe to increase safety for human volunteers in 
toxicokinetic studies".<br>
Risk Analysis 25:1559-1571.</li><p>

<li>Brochot C., Marchand S., Couet W., Gelman A., Bois F., 2004,<br>
"Extension of the isobolographic approach to interactions studies between 
more than two drugs: Illustration with the convulsant interaction between 
pefloxacin, norfloxacin and theophylline in rats".<br>
Journal of Pharmaceutical Sciences, 93:553-562.</li><p>

<li>Brochot C., Smith T.J., Bois F., 2007,<br>
"Development of a physiologically based toxicokinetic model for butadiene 
and four major metabolites in humans: Global sensitivity analysis for 
experimental design issues".<br>
Chemico-Biological Interactions, 167:168-183.</li><p>

<li>Cancre N., Bois F., et al., 1999,<br>
"Screening blood donations for hepatitis C in central Africa: Analysis 
of a risk- and cost-based decision tree".<br>
Medical Decision Making, 19:296-306.</li><p>

<li>Cancre N., Tall A., et al., 2000,<br>
"Bayesian analysis of an epidemiological model of P. falciparum malaria 
infection in Ndiop, Senegal".
American Journal of Epidemiology, 152:760-770.</li><p>

<li>Chiu W.A., Bois F., 2006,<br>
"Revisiting the population toxicokinetics of tetrachloroethylene".<br>
Archives of Toxicology, 80:386-386.</li><p>

<li>Chiu W.A., Bois F., 2007,<br>
"An approximate method for population toxicokinetic analysis with aggregated 
data".<br>
Journal of Agricultural, Biological, and Environmental Statistics, 
12:346-363.</li><p>

<li>Chiu W.A., Micallef S., Monster A.C., Bois F., 2007,<br>
"Toxicokinetics of inhaled trichloroethylene and tetrachloroethylene in 
humans at 1 ppm: Empirical results and comparisons with previous studies".<br>
Toxicological Sciences, 95:23-36.</li><p>

<li>Covington T.R., Gentry P.R., et al., 2007,<br>
"The use of Markov chain Monte Carlo uncertainty analysis to support a 
Public Health Goal for perchloroethylene",<br>
Regulatory Toxicology and Pharmacology, 47:1-18.</li><p>

<li>David, R. M., H. J. Clewell, et al., 2006,<br>
"Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations."<br>
Regulatory Toxicology and Pharmacology 45: 55-65.</li><p>

<li>Diack C., Bois F., 2005,<br>
"Pharmacokinetic-pharmacodynamic models for 
categorical toxicity data,"<br>
Regulatory Toxicology and Pharmacology, 41:55-65.</li><p>

<li>Eisenberg J.N, Seto E., et al, 1996,<br>
"Quantifying water pathogen risk in an epidemiological framework",<br>
Risk Analysis, 16:549-563.</li><p>

<li>Franks S.J., Spendiff M.K., et al., 2006,<br>
"Physiologically based pharmacokinetic modelling of human
exposure to 2-butoxyethanol",<br>
Toxicology Letters 162 (2006) 164úÙÚÛ173.</li><p>

<li>Gelman A., Bois F., Jiang J., 1996,<br>
"Physiological pharmacokinetic analysis using population modeling and 
informative prior distributions,"<br> 
Journal of the American Statistical Association, 91:1400-1412.</li><p>

<li>Hack E.C., 2006,<br>
"Bayesian analysis of physiologically based toxicokinetic and 
toxicodynamic models".<br>
Toxicology, 221:241-248.</li><p>

<li>Hack E.C., Chiu W.A, et al., 2006,<br>
"Bayesian population analysis of a harmonized physiologically based 
pharmacokinetic model of trichloroethylene and its metabolites",
Regulatory Toxicology and Pharmacology, 46:63-83.</li><p> 

<li>Johanson G., Jonsson F., Bois F., 1999,<br>
"Development of new technique for risk assessment using physiologically 
based toxicokinetic models",<br>
American Journal of Industrial Medecine, Suppl. 1:101-103.</li><p>

<li>Jonsson F, Jonsson E.N., Bois F., Marshall S., 2007, The application of a Bayesian approach to the analysis of a complex, mechanistically based model, Journal of Biopharmaceutical Statistics, 17:65-92.</li><p>

<li>Jonsson F., Bois F., Johanson G., 2001, Assessing the reliability of PBPK models using data from methyl chloride-exposed, non-conjugating human subjects, Archives of Toxicology, 75:189-199.</li><p>

<li>Jonsson F., Bois F., Johanson G., 2001, Physiologically based pharmacokinetic modeling of inhalation exposure of humans to dichloromethane during moderate to heavy exercise, Toxicological Sciences, 59:209-218.</li><p>

<li>Jonsson, F. and G. Johanson, 2003,<br>
"The Bayesian population approach to physiological toxicokinetic-toxicodynamic models - An example using the MCSim software."<br>
Toxicology Letters 138: 143-150.</li><p>

<li>Liao K.H., Tan Y.-M., et al.,2007,<br>
"Bayesian estimation of pharmacokinetic and pharmacodynamic parameters 
in a mode-of-action-based cancer risk assessment for chloroform",<br>
Risk Analysis, 27:1535-1551.</li><p>

<li>Lin H.I., Berzins D.W., et al., 2004,<br>
"A Bayesian approach to parameter estimation for a crayfish (procambarus spp.)
bioaccumulation model".<br>
Environmental Toxicology and Chemistry: Vol. 23, No. 9 pp. 2259úÙÚÛ2266.</li><p>

<li>Loizou G., Spendiff M., 2005,<br>
"A human PBPK model for ethanol describing inhibition of gastric motility",<br>
Journal of Molecular Histology, 35:687-696.</li><p>

<li>Lyons M.A., Yang R.S.H, 2008,<br>
"Computational toxicology of chloroform: reverse dosimetry using Bayesian 
inference, Markov chain Monte Carlo simulation, and human biomonitoring 
data",<br>
Environmental Health Perspectives, 116:1040úÙÚÛ1046.</li><p>

<li>Marino, D. J., H. Clewell, et al., 2006,<br>
"Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK 
and dose-response modeling in mice".<br>
Regulatory Toxicology and Pharmacology 45: 44-54.</li><p>

<li>Mezzetti M., Ibrahim J.G., et al., 2003,<br>
"A Bayesian compartmental model for the evaluation of 1,3-butadiene 
metabolism".<br>
Journal of the Royal Statistical Society, Series C, 52:291-305.</li><p>

<li>Micallef S., Amzal B., Bach V., Chardon K., Tourneux P., Bois F., 2007, Sequential updating of a new dynamic pharmacokinetic model for caffeine in premature neonates, Clinical Pharmacokinetics, 46:59-74.</li><p>

<li>Micallef, S., Bois F., 2004, [Application of physiological models to toxicokinetic data analysis], Journal de la Societe FranÅÁaise de Statistique, 145:15-32.</li><p>

<li>Micallef, S., Brochot, C., Bois F., 2005, [Bayesian statistical analysis of toxicokinetic data], Environnement, Risque et Sante, 4:21-34.</li><p>

<li>Nong, A., Y. M. Tan, et al., 2008,<br>
"Bayesian calibration of a
physiologically based pharmacokinetic/pharmacodynamic model of
carbaryl cholinesterase inhibition."<br>  
Journal of Toxicology and Environmental Health - Part A - Current Issues 71(20):
1363-1381.</li><p>

<li>Smith T., Bois F., Lin Y.-S., Brochot C., Micallef S., Kim D., Kelsey K.T., 2008, Quantifying heterogeneity in exposure-risk relationships using exhaled breath biomarkers for 1,3-butadiene exposures, Journal of Breath Research, 2:037018 (10 p.)</li><p>

<li>Smith T., Lin Y.-S., Mezzetti L., Bois F., Kelsey K., Ibrahim J., 2001, Genetic and dietary factors affecting human metabolism of 1,3-butadiene, Chemico-Biological Interactions, 135-136, special issue):407-428.</li><p>

<li>Spear R., Bois F., 1994, Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results, Environmental Health Perspectives, 102(suppl. 11):61-66.</li><p>

<li>Spear R., Bois F., et al., 1991,<br>
"Modeling benzene pharmacokinetics: Calibration and parametric sensitivity 
across three sets of animal data",<br>
Risk Analysis, 11:641-654.</li><p>

<li>Verotta D., 2005,<br>
"Models and estimation methods for clinical HIV-1 data",<br>
Journal of Computational and Applied Mathematics, 184:275-300.</li><p>

<li>Watanabe K., Bois F., 1996, Interspecies extrapolation of physiological pharmacokinetic parameter distributions, Risk Analysis, 16:741-754.</li><p>

<li>Watanabe K.H., Bois F., et al., 1994,<br>
"Benzene toxicokinetics in humans: Bone marrow exposure to metabolites",<br>
Occupational and Environmental Medicine, 51:414-420.</li><p>

<li>Watanabe K.H., Lin H.-I., 2005,<br>
"Bayesian estimation of kinetic rate constants in a food-web model
of polycyclic aromatic hydrocarbon bioaccumulation",<br>
Ecological Modelling 181:229úÙÚÛ246.</li><p>

<li>Woodruff T., Bois F., et al., 1992,<br>
"Structure and parametrization of toxicokinetic models: Their impact on 
model predictions",<br>
Risk Analysis, 12:189-201.</li><p>

<li>Woodruff T.J., Bois F., 1993,<br>
"Optimization issues in physiological toxicokinetic modeling: A case study 
with benzene",<br>
Toxicology Letters, 69:181-196.</li><p>

<li>Yokley K. Tran H.T., et al., 2006<br>
"Physiologically-based pharmacokinetic modeling of benzene in humans: 
A Bayesian approach",<br>
Risk analysis, 26:925-943.</li><p>

</ol>

</body> </html> 
